Editor-in-Chief: Alaa Abd-Elsayed, MD

Abstract
- 2026;10;289-292 Microfragmented Adipose Tissue (MFAT) Injection for Refractory Generator Pocket Pain (GPP) in Spinal Cord Stimulation (SCS): A Case Report
Case Report
Patrizia Vendramin, MD, Alvise Martini, MD, Eleonora Bonora, MD, Michael Tomasi, MD, Nicola Pozzobon, MD, Luca Polati, MD, Leonardo Gottin, MD, Massimo Parolini, MD, Enrico Polati, MD, and Vittorio Schweiger, MD.
BACKGROUND: Generator pocket pain (GPP) may develop in spinal cord stimulation (SCS) patients, with a frequency ranging from 0.9% to 64%. While several treatments have been proposed, the only available options for SCS patients experiencing refractory pain are implantable pulse generator (IPG) relocation or removal.
CASE REPORT: We treated a 62-year-old man with late-onset refractory GPP using the autologous microfragmented adipose tissue (MFAT) injection into the IPG pocket. A total of 30 mL of MFAT harvested from abdominal fat was injected. The procedure was well tolerated, with no adverse events. The patient reported a significant reduction in pain intensity immediately after the injection, with his visual analog scale (VAS) score decreasing from 80 to 20/100. At the third-month follow-up, he continued to experience the same level of pain relief.
CONCLUSION: The autologous MFAT injection in refractory GPP patients is a promising salvage option. However, additional cases will be needed to better evaluate the efficacy and long-term outcomes of this treatment.
KEYWORDS: Generator pocket pain, microfragmented adipose tissue, spinal cord stimulation (SCS)




